HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease - Wikidata - wikimedia - TriplyDB

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

http://www.wikidata.org/entity/Q33998193

about

Chromogranin A is an autoantigen in type 1 diabetes Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity Vaccine against autoimmune disease: antigen-specific immunotherapy Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation Structural and Functional Studies of trans -Encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) Protein Molecule T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity Celiac disease in Iran: a systematic review and meta-analysis.A B-Cell Gene Signature Correlates With the Extent of Gluten-Induced Intestinal Injury in Celiac Disease.The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology.Celiac disease: how complicated can it get?On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference.Novel therapies for coeliac disease Can dietary fibre help provide safer food products for sufferers of gluten intolerance? A well-established biophysical probe may help towards providing an answer.Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation Maize prolamins resistant to peptic-tryptic digestion maintain immune-recognition by IgA from some celiac disease patients.Modeling of celiac disease immune response and the therapeutic effect of potential drugs Celiac disease: risk assessment, diagnosis, and monitoring.Wheat.Trans heterodimer between two non-arthritis-associated HLA alleles can predispose to arthritis in humanized mice Role of genetic alterations in the NLRP3 and CARD8 genes in health and disease.Liver complications in celiac disease How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited.Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules.Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders.Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing Celiac disease: pathogenesis of a model immunogenetic disease.The characterization of the repertoire of wheat antigens and peptides involved in the humoral immune responses in patients with gluten sensitivity and Crohn's disease Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation.Rapid isolation of gluten-digesting bacteria from human stool and saliva by using gliadin-containing plates.Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease.

P2860

Q24605199-2F9FA771-7161-4235-BFEF-DDA56BCEA313 Q24642835-B7785ED2-167E-417E-A0A8-5CB63A06A079 Q26800973-B0831F9F-3213-4036-91F8-6CC2EB54B33E Q27028121-7C14D074-07F8-473F-88F4-D6E448C9FA49 Q27321328-237A608B-ACF8-40F7-B6BC-036825EA2DDA Q27677454-56425AF5-C964-4488-A723-A54C5606FBB0 Q27690116-7161FFEF-9C85-450D-B3FE-14BDB3FDD12F Q28084487-4E7A6462-74BD-4170-B3B9-0D7B2E54274D Q28484010-D6B5D104-A330-4A80-859A-F07D22A35CA9 Q30411842-50061BC8-C8D5-482C-97A3-9F7528652D29 Q30990395-D322DDF2-9945-40BC-8D46-2271D7820B24 Q33609486-7988CDB8-ABDD-4EC3-9681-45F04B5A3FDC Q33626963-0C076145-EAF1-4789-8592-26809A15C542 Q33761129-F3F4C380-B75A-4143-899D-123FE6D31735 Q33956436-8BB72972-FB82-4BFE-8DAB-E46B7F209057 Q34128112-59688F03-4764-4646-BE81-FB87D3EF829A Q34150236-93810224-BD39-40EB-8AB6-C15786F2A872 Q34165724-1715A2AB-3D36-4477-839E-31F9AFF66063 Q34170574-0E3BD668-CA08-40B4-AC2D-B62378CD9997 Q34272450-011359E2-59EF-4FD8-BBCA-94EC2BFADD29 Q34314995-A294EEAD-D714-4234-B32E-141358714D03 Q34635585-E16D9952-DCEC-41CE-8051-9DCDC2ED996D Q34798574-560D65A7-0CC5-4610-A97D-57B8814D5225 Q34831592-CA5E2741-872E-4EA4-BDC2-1C2296A004A3 Q34977252-216C0C68-1C43-47B3-A34C-2EB65C533341 Q35019501-67343590-AEF5-4618-B15A-1974098644AB Q35144145-DD5F7B15-5ACE-4A55-B210-03F5BA00586B Q35540224-EAE630FE-71AB-40C5-9843-F00ABE0F13A5 Q35796906-4753DB62-AF9B-4EF8-9569-7AC128412A11 Q35835769-B9B4C631-0E8D-41AE-ADE9-7A6C3040D91C Q35951955-F2AA0E2C-75FF-4E41-A4F9-A160F8A29E6F Q36190939-17DE69E9-924E-47A8-A286-0BBA53C8C6F6 Q36345930-4B000052-9037-4D6F-BE86-CE8B7CC21B70 Q36351049-3D869083-E7D9-429D-A4EF-11AC98D8CBCA Q36698131-5A45937D-FA6B-42FC-AE19-97A5BCCA870C Q36858402-7D148AD4-21FE-4839-80A9-87F85E2F6DBD Q36865485-392D98EB-30C6-4A68-9BEE-89FFB9F9150A Q37071537-68D031A4-F233-47AC-B21B-09FC7CBC074B Q37144602-EA5929E6-350D-4CE9-B7E0-C7D577EA9442 Q37247193-1D34F055-D0BB-4F23-B0B0-B0A61D5463DA

P2860

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

http://www.wikidata.org/entity/Q33998193

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

@ast

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

@en

type

label

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

@ast

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

@en

prefLabel

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

@ast

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

@en

P1433

Q33998193-0FD2B3CF-9D2B-4867-9887-B9DF03C658A7

P1476

Q33998193-897A9E1C-AB5E-4320-AA4B-F46DDBAC804E

P2093

Q33998193-1D11C118-FE89-4810-8E85-CA9424A00CBE

Q33998193-3FDFC034-CB85-4918-851B-9527B8BDEEF9

Q33998193-57EE3E50-D82A-40AC-A5DB-6CF6595149B7

Q33998193-5A786832-FD71-4EB8-9A57-F408708BEA40

Q33998193-6707BEC6-ED64-4C61-96D7-3078C6D8D1ED

Q33998193-A10BC54C-0401-41AE-8026-AD83667552ED

Q33998193-D734F5B7-8312-4EFC-A339-F3C18A038952

Q33998193-DFD95C60-E921-4359-8F7E-9D993B4F7E83

Q33998193-FB0DD840-48DF-4079-BD0F-A16987F416C2

P2860

Q33998193-126B4DFF-5FB9-4F7B-9839-A40818C344F2

Q33998193-18B4B8ED-F5B1-482C-A9C9-4C0199FB242F

Q33998193-195D308B-67D7-40C9-B8B5-F93DF6CF23A2

Q33998193-23717CFF-23B6-4B53-A3C5-8ADD9C1AFDD9

Q33998193-2B569299-9EA2-469A-8DB7-7000E993C62F

Q33998193-2E73E537-3288-42DB-B503-AA56FF290F60

Q33998193-2EBBF99C-6AEF-4992-9218-A24418B4F1B9

Q33998193-3BF0D34B-C265-41F9-9F61-556602C8F3CE

Q33998193-48646003-8ECA-4360-A298-B4DF6CFFED22

Q33998193-4DD497A5-75AA-4399-B204-6DFC7BD645F3

P304

Q33998193-C0C07AA2-CA5A-41F4-8C03-C2EBBFD0612C

P31

Q33998193-0D02D5F2-8637-436D-9C9B-68C2058D4F92

P356

Q33998193-85CA1D2D-2D14-4CE6-8FD2-FED9156A9844

P407

Q33998193-72685C6C-990F-4F13-A254-A3E007B3C93D

P433

Q33998193-484744F5-EEF4-4D75-8488-27B5637F495E

P478

Q33998193-CC276182-F656-42D7-9E27-3754C3ECE5C9

P577

Q33998193-4BAC48A1-E9BA-43D9-8A15-0FE9C205BFC9

P5875

Q33998193-78EFC0F0-E3D8-42FD-AA02-57CFD51E3860

P698

Q33998193-2FD23735-83DE-444D-BF35-474E9D547489

P932

Q33998193-0C26E47A-9688-4199-AB36-B367DB6774C3

P356

P1433

Journal of Clinical Investigation

P1476

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

@en

P2093

Burkhard Fleckenstein

http://www.w3.org/2001/XMLSchema#string

Günther Jung

http://www.w3.org/2001/XMLSchema#string

Helene Arentz-Hansen

http://www.w3.org/2001/XMLSchema#string

Knut E A Lundin

http://www.w3.org/2001/XMLSchema#string

Ludvig M Sollid

http://www.w3.org/2001/XMLSchema#string

Melinda Ráki

http://www.w3.org/2001/XMLSchema#string

Oyvind Molberg

http://www.w3.org/2001/XMLSchema#string

Stig Tollefsen

http://www.w3.org/2001/XMLSchema#string

William W Kwok

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase

Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes

Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation

Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.

In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

Molecular basis of celiac disease.

The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides.

Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.

Structural principles of MHC class II antigen presentation.

P304

2226-2236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI27620

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6908797

http://www.w3.org/2001/XMLSchema#string

P698

16878175

http://www.w3.org/2001/XMLSchema#string

P932

1518792

http://www.w3.org/2001/XMLSchema#string